Literature DB >> 7878639

Characterization of a novel streptokinase produced by Streptococcus equisimilis of non-human origin.

S T Nowicki1, D Minning-Wenz, K H Johnston, R Lottenberg.   

Abstract

Streptokinases are proteins with plasminogen activator activity produced by certain hemolytic streptococci. We previously identified equine streptococcal isolates which produced streptokinases (ESKs) that bound both human and equine plasminogen but only readily activated equine plasminogen (14). This property was exploited to purify a representative ESK produced by Streptococcus equisimilis strain 87-542-W. Affinity chromatography with human plasminogen resulted in the isolation of a M(r) approximately 49,000 molecule with two isoforms. This ESK was subsequently compared to well characterized streptokinases (HSKs) that efficiently activate human plasminogen. Differences in streptokinases were identified in the highly conserved amino-terminal amino acid sequence, peptide maps, and antigenic properties, and these differences were supported by DNA hybridization studies. These results indicate that the family of proteins identified as streptokinases has much greater diversity than previously appreciated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7878639

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Characterization of PauB, a novel broad-spectrum plasminogen activator from Streptococcus uberis.

Authors:  Philip N Ward; James A Leigh
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

2.  Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma.

Authors:  B Schroeder; M D Boyle; B R Sheerin; A C Asbury; R Lottenberg
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

3.  Cloning, expression, sequence analysis, and characterization of streptokinases secreted by porcine and equine isolates of Streptococcus equisimilis.

Authors:  A R Caballero; R Lottenberg; K H Johnston
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice.

Authors:  Hongmin Sun; Yuanxi Xu; Izabela Sitkiewicz; Yibao Ma; Xixi Wang; Bryan D Yestrepsky; Yuping Huang; Martian C Lapadatescu; Martha J Larsen; Scott D Larsen; James M Musser; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

5.  Reduced thrombin generation increases host susceptibility to group A streptococcal infection.

Authors:  Hongmin Sun; Xixi Wang; Jay L Degen; David Ginsburg
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

6.  Conservation of the organization of the streptokinase gene region among pathogenic streptococci.

Authors:  C Frank; K Steiner; H Malke
Journal:  Med Microbiol Immunol       Date:  1995-10       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.